| 瑞戈非尼联合纳武利尤单抗治疗晚期胃癌或结直肠癌的Ⅰb期临床研究 |
| |
| 引用本文： | 郜辉,王晰程,赖晓嵘.瑞戈非尼联合纳武利尤单抗治疗晚期胃癌或结直肠癌的Ⅰb期临床研究[J].循证医学,2001,20(4):217-221. |
| |
| 作者姓名： | 郜辉 王晰程 赖晓嵘 |
| |
| 作者单位： | 1.郑州大学附属郑州中心医院肿瘤康复科,郑州 450007;2.北京大学临床肿瘤学院、北京大学肿瘤 医院暨北京市肿瘤防治研究所消化肿瘤内科、恶性肿瘤发病机制及转化研究教育部重点实验室, 北京 100142;3.广东省人民医院肿瘤中心、广东省医学科学院, 广州 510080 |
| |
| 摘 要： |
|
A Phase Ⅰb Clinical Study of Regorafenib Plus Nivolumab in Patients With Advanced Gastric Cancer or Colorectal Cancer |
| |
| Reviewers：GAO Hui,WANG Xi-cheng,LAI Xiao-rong.A Phase Ⅰb Clinical Study of Regorafenib Plus Nivolumab in Patients With Advanced Gastric Cancer or Colorectal Cancer[J].The Journal of Evidence-Based Medicine,2001,20(4):217-221. |
| |
| Authors: | Reviewers：GAO Hui WANG Xi-cheng LAI Xiao-rong |
| |
| Institution: | Reviewers'address： 1. Department of Cancer Rehabilitation, The Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou 450007,China;
2. Department of Gastrointestinal Oncology, Peking University School of Oncology, Peking University Cancer Hospital & Institute,The Key Laboratory of Carcinogenesis and Translational Research （Ministry of Education）, Beijing 100142, China |
| |
| Abstract: | |
| |
| Keywords: | |
|
| 点击此处可从《循证医学》浏览原始摘要信息 |
| 点击此处可从《循证医学》下载免费的PDF全文 |
|
